NM_020041.3:c.844G>A
Variant summary
The NM_020041.3(SLC2A9):c.844G>A (p.Val282Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene SLC2A9 is a tumor suppressor gene (CancerMine: 2 TSG citations). The variant allele was found at a cumulative frequency of 0.229 (AC=370,036) in the gnomAD database across 1,613,968 control chromosomes, including 46,504 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.429. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★). The variant has been observed in cBioPortal in 4 samples across 3 studies and 3 cancer types; somatic enrichment level: SUPPORTING_LOW (Observed in a small number of cBioPortal cases.). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_020041.3 missense
Scores
Clinical Significance
Conservation
Publications
- hypouricemia, renal, 2Inheritance: AR, AD, SD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
- hereditary renal hypouricemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Likely_benign. The variant received -5 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| B1High frequency in general population | GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.429 — exceeds 1% threshold (B1 applied) | ||
| B3Computational evidence does not support deleterious effect | Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3 |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_020041.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
SLC2A9 | MANE Select | c.844G>A p.Val282Ile | missense | Exon 7 of 12 | Prot: NP_064425.2 | |
SLC2A9 | c.757G>A p.Val253Ile | missense | Exon 8 of 13 | Prot: NP_001001290.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
SLC2A9 | TSL:1MANE Select | c.844G>A p.Val282Ile | missense | Exon 7 of 12 | Prot: ENSP00000264784.3 UniProt: | |
SLC2A9 | TSL:1 | c.757G>A p.Val253Ile | missense | Exon 8 of 13 | Prot: ENSP00000311383.3 UniProt: | |
SLC2A9 | TSL:1 | n.878G>A | non_coding_transcript_exon | Exon 8 of 12 | Prot: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.282 | AC:42936 | Hom:6956 | AN:152072 | Cov:33 |
GnomAD2 exomes | AF: 0.243 | AC:61149 | AN:251162 | ||
GnomAD4 exome | AF: 0.224 | AC:327053 | Hom:39537 | AN:1461778 | Cov:38 |
GnomAD4 genome | AF: 0.282 | AC:42983 | Hom:6967 | AN:152190 | Cov:33 |
TOPMed (Bravo) | AF: 0.300 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.248 | AC:83850 | Hom:11588 | AN:338330 | |
Local & regional cohorts 11 sources | |||||
ABraOM SABE-WGS-1171 | AF: 0.289 | AC:677 | Hom:106 | AN:2342 | |
ChinaMAP Phase 1 | AF: 0.0193 | ||||
Denmark Genome | AF: 0.233 | AC:70 | AN:300 | ||
ESP6500 (Exome Variant Server) | AF: 0.286 | AC:3724 | AN:13006 | ||
GenomeAsia100K | AF: 0.153 | AC:532 | AN:3478 | ||
Korea4K (4,157 Koreans) | AF: 0.0100 | AC:73 | AN:7234 | ||
Qatari Genome | AF: 0.218 | AC:438 | AN:2010 | ||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.00847 | AC:1039 | Hom:6 | AN:122716 | |
Turkish Variome | AF: 0.270 | AC:1804 | Hom:273 | AN:6670 | |
UK10K | AF: 0.218 | AC:1646 | AN:7562 | ||
WBBC (Westlake BioBank for Chinese) pilot | AF: 0.0126 | AC:113 | Hom:1 | AN:8960 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.210 * | 2333 | 11106 | 0.208 * | 3654 | 17598 |
BipEx | 0.209 | 5950 | 28420 | 0.211 | 6087 | 28844 |
Epi25 | 0.221 | 9288 | 41958 | 0.243 | 16286 | 66886 |
SCHEMA | 0.201 | 24261 | 120558 | 0.206 | 38834 | 188774 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Benign | 9.3 | |
AlphaMissense | Benign | 0.17 | |
BayesDel_addAF | Benign | -0.64 | T |
BayesDel_noAF | Benign | -0.55 | |
CADD | Benign | 4.5 | |
DANN | Benign | 0.95 | |
DEOGEN2 | Benign | 0.10 | T |
Eigen | Benign | -0.58 | |
Eigen_PC | Benign | -0.64 | |
FATHMM_MKL | Uncertain | 0.88 | D |
FuncVEP CTI | Benign | 0.14 | |
GPN-Star LLR | N/A | -1.3 | |
GPN-Star score | N/A | 1.3 | |
LIST_S2 | Benign | 0.72 | T |
MetaRNN | Benign | 0.028 | T |
MetaSVM | Benign | -0.98 | T |
Mutation Taster | N/A | 100/0 | polymorphism (auto) |
MutationAssessor | Uncertain | 2.1 | M |
PhyloP100 | Benign | 1.8 | |
popEVE | Benign | -3.0 | |
PrimateAI | Benign | 0.30 | T |
PROVEAN | Benign | -0.47 | N |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.1 | |
REVEL | Benign | 0.23 | |
Sift | Benign | 0.16 | T |
Sift4G | Benign | 0.25 | T |
Varity_R | N/A | 0.052 | |
VESM-3B | Benign | -5.8 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.010 | |
SpliceAI score (max) | Benign | 0.020 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.